Effects of Berberine on Expression of LOX-1 and SR-BI in Human Macrophage-Derived Foam Cells Induced by ox-LDL

被引:54
作者
Guan, Siming [1 ]
Wang, Bin [1 ]
Li, Wei [1 ]
Guan, Jinghuan [2 ]
Fang, Xin [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Geriatr, Wuhan 430022, Peoples R China
[2] Hosp Combining Tradit Chinese Med & Western Med W, Wuhan 430024, Peoples R China
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 2010年 / 38卷 / 06期
关键词
Berberine; Foam Cell; Lectin-Like ox-LDL Receptor-1; Scavenger Receptor Class B Type I; LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; IN-VITRO; CHOLESTEROL; MECHANISM; PROMOTES; STATINS; PATHWAY; RABBITS; KINASE;
D O I
10.1142/S0192415X10008548
中图分类号
R [医药、卫生];
学科分类号
100218 [急诊医学];
摘要
This study investigates the effects of beriberine on the expression of lectin-like ox-LDL receptor-1 (LOX-1), scavenger receptor A (SR-A), SR class B type I (SR-BI) and ATP-binding cassette transporter A1 (ABCA1) in human macrophage-derived foam cells induced by ox-LDL. Different concentrations of Berberine were co-cultured with THP-1 derived foam cells. The mRNA and protein expressions of LOX-1, SR-A, SR-BI and ABCA1 were determined by RT-PCR and Western blot analysis, respectively. Ox-LDL significantly increased the expression of LOX-1 and inhibited the expression of SR-BI in a dose-and time-dependent manner. Berberine significantly inhibited the effects of ox-LDL in a dose-and time-dependent manner. Moreover, ox-LDL significantly promoted ABCA1 expression. However, berberine had no effect on SR-A or ABCA1 expression. Berberine can inhibit the expression of LOX-1 and promote the expression of SR-BI in macrophage-derived foam cells. Therefore, berberine could be used to treat atherosclerotic diseases.
引用
收藏
页码:1161 / 1169
页数:9
相关论文
共 23 条
[1]
Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [J].
Abidi, P ;
Zhou, Y ;
Jiang, JD ;
Liu, JW .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2170-2176
[2]
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J].
Brusq, Jean-Marie ;
Ancellin, Nicolas ;
Grondin, Pascal ;
Guillard, Raphaelle ;
Martin, Sandrine ;
Saintillan, Yannick ;
Issandou, Marc .
JOURNAL OF LIPID RESEARCH, 2006, 47 (06) :1281-1288
[3]
Cho BJ, 2005, MOL CELLS, V20, P429
[4]
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice [J].
de Haan, Willeke ;
van der Hoogt, Caroline C. ;
Westerterp, Marit ;
Hoekstra, Menno ;
Dallinga-Thie, Geesje M. ;
Princen, Hans M. G. ;
Romijn, Johannes A. ;
Jukema, J. Wouter ;
Havekes, Louis M. ;
Rensen, Patrick C. N. .
ATHEROSCLEROSIS, 2008, 197 (01) :57-63
[5]
Guan SM, 2003, CHINESE MED J-PEKING, V116, P923
[6]
Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I [J].
Han, JH ;
Nicholson, AC ;
Zhou, XY ;
Feng, JW ;
Gotto, AM ;
Hajjar, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16567-16572
[7]
Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in watanabe heritable hyperlipidemic rabbits - A new pleiotropic effect of statins [J].
Hofnagel, O ;
Luechtenborg, B ;
Eschert, H ;
Weissen-Plenz, G ;
Severs, NJ ;
Robenek, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) :604-610
[8]
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins [J].
Kong, WJ ;
Wei, J ;
Abidi, P ;
Lin, MH ;
Inaba, S ;
Li, C ;
Wang, YL ;
Wang, ZZ ;
Si, SY ;
Pan, HN ;
Wang, SK ;
Wu, JD ;
Wang, Y ;
Li, ZR ;
Liu, JW ;
Jiang, JD .
NATURE MEDICINE, 2004, 10 (12) :1344-1351
[9]
Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI [J].
Krieger, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :523-558
[10]
The anti-inflammatory potential of berberine in vitro and in vivo [J].
Kuo, CL ;
Chi, CW ;
Liu, TY .
CANCER LETTERS, 2004, 203 (02) :127-137